Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1672601 | 1.00 | TSHR (0.30) | TSHRCYP2C19 | |
| SCHEMBL1672603 | 1.00 | TSHR (0.30) | TSHRCYP2C19 | |
| SCHEMBL2489793 | 1.00 | TSHR (0.30) | TSHRCYP2C19 | |
| SCHEMBL16654228 | 1.00 | TSHR (0.30) | TSHRCYP2C19 | |
| Hydrochloric Acid SCHEMBL742331 | 0.96 | — | — | |
| Hydrochloric Acid SCHEMBL31324651 | 0.96 | — | — | |
| SCHEMBL16639232 | 0.96 | TSHR (0.35) | TSHRCYP2C19 | |
| SCHEMBL18226106 | 0.92 | — | — | |
| SCHEMBL29674979 | 0.92 | — | — | |
| SCHEMBL31241431 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1647 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117865859-A | Preparation method of enantiomerically pure p-toluenesulfonamide | 常州琦诺生物科技有限公司 | 2024-04-12 | — | — | CN | claimed |
| CN-117242062-A | Process for the preparation of intermediates useful in the synthesis of xanthine oxidase inhibitors | 株式会社LG化学 | 2023-12-15 | — | — | CN | claimed |
| CN-117024354-B | Preparation method of Rui Mi Buti Ni | 天津凯莱英制药有限公司 | 2023-12-08 | — | — | CN | claimed |
| CN-117203200-A | Process for preparing xanthine oxidase inhibitors | 株式会社LG化学 | 2023-12-08 | — | — | CN | claimed |
| CN-117143010-A | Bipyridine diamine ligand and preparation method thereof | 山东农业大学 | 2023-12-01 | — | — | CN | claimed |
| CN-117024354-A | Preparation method of Rui Mi Buti Ni | 天津凯莱英制药有限公司 | 2023-11-10 | — | — | CN | claimed |
| EP-4211118-A1 | SUBSTITUTED PYRIMIDINE DERIVATIVES AS NICOTINIC ACETYLCHOLINESTERASE RECEPTOR ALPHA 6 MODULATOR | Cerevance, Inc. (US) | 2023-07-19 | — | — | EP | claimed |
| CN-112250675-B | Tyrosine kinase inhibitor containing amide structure and preparation method thereof | 深圳市第二人民医院(深圳市转化医学研究院) | 2023-06-27 | — | — | CN | claimed |
| CN-112300138-B | Tyrosine kinase inhibitor containing ester group structure and preparation method thereof | 深圳市第二人民医院(深圳市转化医学研究院) | 2023-06-27 | — | — | CN | claimed |
| CN-116120219-A | Polysubstituted pyrrole compound, preparation method thereof and application thereof in preparation of HBV capsid protein inhibitor | 吉斯凯(苏州)制药有限公司 | 2023-05-16 | — | — | CN | claimed |
| WO-2006119417-A1 | PROCESSES FOR THE PREPARATION OF O-(6-PYRAZOL-1-YL-PYRIDIN-3-YLMETHYL)-HYDROXYLAMINE | ENANTA PHARMACEUTICALS, INC. (US) | 2006-11-09 | — | — | WO | claimed |
| CN-1854128-A | Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds | MASSACHUSETTS INST TECHNOLOGY (US) | 2006-11-01 | — | — | CN | claimed |
| CN-1266112-C | Copper-catalyzed carbon-heteroatom and carbon-carbon bond formation | MASSACHUSETTS INST TECHNOLOGY (US) | 2006-07-26 | — | — | CN | claimed |
| CN-1684944-A | method for copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds | MASSACHUSETTS INST TECHNOLOGY (US) | 2005-10-19 | — | — | CN | claimed |
| EP-1534671-A2 | COPPER-CATALYZED FORMATION OF CARBON-HETEROATOM AND CARBON-CARBON BONDS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2005-06-01 | — | — | EP | claimed |
| CN-1518534-A | Copper-catalyzed carbon-heteroatom and carbon-carbon bond formation | 麻省理工学院 | 2004-08-04 | — | — | CN | claimed |
| EP-1390340-A1 | COPPER-CATALYZED FORMATION OF CARBON-HETEROATOM AND CARBON-CARBON BONDS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2004-02-25 | — | — | EP | claimed |
| WO-2004013094-A2 | COPPER-CATALYZED FORMATION OF CARBON-HETEROATOM AND CARBON-CARBON BONDS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2004-02-12 | — | — | WO | claimed |
| US-20030065187-A1 | Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2003-04-03 | — | — | US | claimed |
| WO-2002085838-A1 | COPPER-CATALYZED FORMATION OF CARBON-HETEROATOM AND CARBON-CARBON BONDS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2002-10-31 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030065187-A1 | Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds | ADH5, CBR3, ALDH3A1 | TSHR 3079/4885CYP2C19 351/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.